Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
Cemiplimab for Squamous Cell Carcinoma
Recruiting3 awardsPhase 1 & 2
Boston, Massachusetts
This trial is studying Cemiplimab to see how well it works in treating patients with advanced cutaneous squamous cell carcinoma who have had a hematopoietic stem cell transplant or kidney transplant.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service